Table 2 Factors associated with visceral fat mass.
From: Endotoxins are associated with visceral fat mass in type 1 diabetes
B | 95% Wald Confidence Interval | Wald Chi-squared | p | ||
|---|---|---|---|---|---|
Model 1 | LPS activity | 1253.2 | 386.4–2120.0 | 8.029 | 0.005 |
Women | −595.1 | −810.5–−379.6 | 29.303 | <0.001 | |
Age | 12.0 | 3.1–20.9 | 7.038 | 0.008 | |
Nephropathy | 211.4 | −52.6–475.4 | 2.463 | 0.117 | |
hsCRP | 64.7 | 38.4–91.0 | 23.299 | <0.001 | |
Model 2 | LPS activity | 848.6 | 48.4–1648.8 | 4.320 | 0.038 |
Women | −309.8 | −524.6–−95.1 | 7.995 | 0.005 | |
Age | 4.9 | −3.4–13.3 | 1.344 | 0.246 | |
Nephropathy | −19.0 | −269.8–231.8 | 0.022 | 0.882 | |
hsCRP | 32.8 | 6.9–58.6 | 6.174 | 0.013 | |
eGDR | −158.0 | −205.9–−110.1 | 41.763 | <0.001 | |
Model 3 | LPS activity | −678.9 | −1558.8–201.1 | 2.286 | 0.131 |
Women | −171.5 | −373.5–30.6 | 2.766 | 0.096 | |
Age | 6.1 | −1.6–13.8 | 2.392 | 0.122 | |
Nephropathy | 0.1 | −230.3–230.6 | 0.000 | 0.999 | |
hsCRP | 10.1 | −14.7–34.9 | 0.635 | 0.426 | |
eGDR | −126.7 | −171.8–−81.6 | 30.292 | <0.001 | |
Triglycerides | 452.6 | 309.3–596.0 | 38.295 | <0.001 | |
Model 4 | LPS activity | 453.8 | −737.1–1644.8 | 0.558 | 0.455 |
Women | −156.4 | −355.3–42.5 | 2.376 | 0.123 | |
Age | 5.4 | −2.2–13.0 | 1.959 | 0.162 | |
Nephropathy | 1.3 | −225.2–227.7 | 0.000 | 0.991 | |
hsCRP | 5.0 | −19.7–29.7 | 0.158 | 0.691 | |
eGDR | −125.0 | −169.3–−80.6 | 30.519 | <0.001 | |
Triglycerides | 732.7 | 486.0–979.4 | 33.892 | <0.001 | |
LPS*TG interaction | −634.2 | −1092.6–−175.7 | 7.350 | 0.007 |
